A5039678641- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Venous Thromboembolism Diagnosis and Management
- Cerebrovascular and Carotid Artery Diseases
- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Central Venous Catheters and Hemodialysis
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Aortic aneurysm repair treatments
- Lipoproteins and Cardiovascular Health
- Renal and Vascular Pathologies
- Acute Kidney Injury Research
- Diagnosis and Treatment of Venous Diseases
- Cardiac Structural Anomalies and Repair
- Cardiac Valve Diseases and Treatments
- Cardiovascular Health and Disease Prevention
- Acute Ischemic Stroke Management
- Coronary Artery Anomalies
- Cardiac, Anesthesia and Surgical Outcomes
- Infectious Aortic and Vascular Conditions
- Radiation Dose and Imaging
- Heart Failure Treatment and Management
- Heparin-Induced Thrombocytopenia and Thrombosis
- Advanced X-ray and CT Imaging
Oklahoma Heart Hospital
2013-2024
University of Oklahoma Health Sciences Center
2012-2023
University of Oklahoma
2007-2023
Oklahoma City University
2015-2021
OU Health
2016-2018
Midwest Cardiovascular Research Foundation
2016-2018
Dallas VA Medical Center
2017-2018
University of Missouri
2018
The University of Texas Southwestern Medical Center
2015-2017
VA North Texas Health Care System
2015-2017
Coronary slow flow phenomenon (CSFP) is defined as delayed coronary opacification in the absence of obstructive artery disease. In present study, we sought to define its prevalence and clinical features.The 1,741 consecutive patients who underwent angiography (CAG) were identified. Those with normal left ventricular ejection fraction arteries included study (n=158). TIMI frame counts calculated, data on demographics, comorbidities, medication use collected. CSFP was count > 27. Multivariate...
There are limited data on femoropopliteal artery stent thrombosis (ST), which is a serious adverse outcome of peripheral interventions.Index procedures resulting in ST were compared with without subsequent the Excellence Peripheral Artery Disease registry. The study had total 724 cases and 604 unique patients. Femoropopliteal occurred 26 patients (4.3%) over median follow-up 6 months post procedure. was more likely to occur men (96.3% versus 82.2%; P=0.026) have an initial intervention for...
Abstract Objective: To compare the effectiveness of accessing common femoral artery (CFA) using fluoroscopic guidance (FG) versus traditional anatomic landmark (TALG) during cardiac catheterization and to determine effect two modalities on appropriateness for use vascular closure devices (VCDs). Background: Previous studies have shown a consistent relationship between head femur CFA, yet there is no prospective data validating superiority fluoroscopy‐assisted CFA access. Methods: A total 972...
The learning curve for new operators performing ultrasound-guided transfemoral access (TFA) remains uncertain.
Background Variations in radiation dose between various X‐ray systems have received limited study. Objective We examined the impact of system type on patient during cardiac catheterization. Methods An anthropomorphic phantom was used a series standardized experiments that involved 15 sec continuous cineangiography 7 projections. Three to seven were performed four commonly systems: Innova IGS (GE Healthcare), Integris Allura FD20 (Philips), Clarity and Artis one (Siemens). Phantom measured...
Use of atherectomy for the treatment peripheral arterial disease (PAD) is increasing as an adjunctive to either conventional or drug-coated balloon angioplasty. There limited data on outcomes in below-the-knee (BTK) endovascular interventions.Data from multicenter Excellence Peripheral Artery Disease (XLPAD) registry (NCT01904851) were analyzed examine predictors use and its associated 1-year patency rate. We 518 BTK procedures performed between January 2005 December 2016.Overall a total...
Our goal was to describe a single-center's experience in managing acute and chronic mesenteric ischemia with endovascular therapies.Open surgical revascularization has been considered the historical gold standard treatment for though it poses considerable morbidity mortality risk. An aging population increased comorbidities makes more attractive option.Consecutive subjects receiving percutaneous interventions from 2004 2010 were identified retrospectively. Information on comorbidities,...
The direct thrombin inhibitor, bivalirudin, is associated with similar efficacy and superior safety in patients undergoing percutaneous coronary intervention. However, the role of inhibitors carotid artery stenting not well defined. objective this study was to compare effectiveness bivalirudin unfractionated heparin (UFH) for stenting. We hypothesized that would be less in-hospital postprocedure bleeding than UFH but rates 30-day ischemic outcomes.We compared incidence hemorrhagic...
Objective We sought to establish the typical location of common femoral artery (CFA) bifurcation, origin and most inferior reflection epigastric (IEA) relative head (FH) whether patient demographics predicted anatomical variations. Background In absence ultrasound guidance or prior imaging, precise CFA bifurcation IEA can only be determined following access site angiography. Fluoroscopic landmarks are commonly used estimate but position is less well characterized. Methods Prospectively...
Coronary artery aneurysm (CAA) formation in the setting of an acute inflammatory state due to connective tissue disease is rare. We report a case rapid progression from ectatic aneursymatic left circumflex coronary leading event patient with rheumatoid arthritis (RA). accelerated growth as it was temporally related lapse treatment and management strategies involved this entity.